Home

cukor Utókor tüsszent inhibit ox ldl zavarjanak Működtet elektróda

Role of Oxidized LDL in Atherosclerosis | IntechOpen
Role of Oxidized LDL in Atherosclerosis | IntechOpen

Oxidized LDL Triggers Pro-Oncogenic Signaling in Human Breast Mammary  Epithelial Cells Partly via Stimulation of MiR-21 | PLOS ONE
Oxidized LDL Triggers Pro-Oncogenic Signaling in Human Breast Mammary Epithelial Cells Partly via Stimulation of MiR-21 | PLOS ONE

The endocytosis of oxidized LDL via the activation of the angiotensin II  type 1 receptor - ScienceDirect
The endocytosis of oxidized LDL via the activation of the angiotensin II type 1 receptor - ScienceDirect

Frontiers | Involvement of LDL and ox-LDL in Cancer Development and Its  Therapeutical Potential
Frontiers | Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential

Elimination of Ox-LDL through the liver inhibits advanced atherosclerotic  plaque progression
Elimination of Ox-LDL through the liver inhibits advanced atherosclerotic plaque progression

PDF] Role of Oxidized LDL in Atherosclerosis | Semantic Scholar
PDF] Role of Oxidized LDL in Atherosclerosis | Semantic Scholar

Oxidized LDL triggers changes in oxidative stress and inflammatory  biomarkers in human macrophages - ScienceDirect
Oxidized LDL triggers changes in oxidative stress and inflammatory biomarkers in human macrophages - ScienceDirect

How Do Oxidized Phospholipids Inhibit LPS Signaling? | Arteriosclerosis,  Thrombosis, and Vascular Biology
How Do Oxidized Phospholipids Inhibit LPS Signaling? | Arteriosclerosis, Thrombosis, and Vascular Biology

The LOX-1 receptor ectopically expressed in the liver alleviates  atherosclerosis by clearing Ox-LDL from the circulation | Molecular  Medicine | Full Text
The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation | Molecular Medicine | Full Text

Silencing p62 reduces ox-LDL-induced M1 polarization and inflammation in  macrophages by inhibiting mTOR/NF-κB signaling pathways - Wei Yang,  Guangming Su, Yanhong Liu, 2022
Silencing p62 reduces ox-LDL-induced M1 polarization and inflammation in macrophages by inhibiting mTOR/NF-κB signaling pathways - Wei Yang, Guangming Su, Yanhong Liu, 2022

Frontiers | Overview of OxLDL and Its Impact on Cardiovascular Health:  Focus on Atherosclerosis
Frontiers | Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis

Difference between OxLDL and MM-LDL. LDL is thought to be modified in a...  | Download Scientific Diagram
Difference between OxLDL and MM-LDL. LDL is thought to be modified in a... | Download Scientific Diagram

Biomedicines | Free Full-Text | Recognition of Oxidized Lipids by  Macrophages and Its Role in Atherosclerosis Development
Biomedicines | Free Full-Text | Recognition of Oxidized Lipids by Macrophages and Its Role in Atherosclerosis Development

Silencing p62 reduces ox-LDL-induced M1 polarization and inflammation in  macrophages by inhibiting mTOR/NF-κB signaling pathways - Wei Yang,  Guangming Su, Yanhong Liu, 2022
Silencing p62 reduces ox-LDL-induced M1 polarization and inflammation in macrophages by inhibiting mTOR/NF-κB signaling pathways - Wei Yang, Guangming Su, Yanhong Liu, 2022

LOX-1 and cancer: an indissoluble liaison | Cancer Gene Therapy
LOX-1 and cancer: an indissoluble liaison | Cancer Gene Therapy

Mechanistic Insights into the Oxidized Low-Density Lipoprotein-Induced  Atherosclerosis
Mechanistic Insights into the Oxidized Low-Density Lipoprotein-Induced Atherosclerosis

An activator of mTOR inhibits oxLDL-induced autophagy and apoptosis in  vascular endothelial cells and restricts atherosclerosis in apolipoprotein  E-/- mice | Scientific Reports
An activator of mTOR inhibits oxLDL-induced autophagy and apoptosis in vascular endothelial cells and restricts atherosclerosis in apolipoprotein E-/- mice | Scientific Reports

Overexpression of hsa_circ_0001445 reverses oxLDL‑induced inhibition of  HUVEC proliferation via SRSF1
Overexpression of hsa_circ_0001445 reverses oxLDL‑induced inhibition of HUVEC proliferation via SRSF1

Oxidised Low Density Lipoprotein (LDL) Modification with Statin Therapy is  Associated with Reduction in Carotid Stenosis | IntechOpen
Oxidised Low Density Lipoprotein (LDL) Modification with Statin Therapy is Associated with Reduction in Carotid Stenosis | IntechOpen

Life | Free Full-Text | LDL-Cholesterol and Platelets: Insights into Their  Interactions in Atherosclerosis
Life | Free Full-Text | LDL-Cholesterol and Platelets: Insights into Their Interactions in Atherosclerosis

Antioxidants | Free Full-Text | LOX-1: Regulation, Signaling and Its Role  in Atherosclerosis
Antioxidants | Free Full-Text | LOX-1: Regulation, Signaling and Its Role in Atherosclerosis

PDF] Role of Oxidized LDL in Atherosclerosis | Semantic Scholar
PDF] Role of Oxidized LDL in Atherosclerosis | Semantic Scholar

Oxidation of LDL by Myeloperoxidase and Reactive Nitrogen Species |  Arteriosclerosis, Thrombosis, and Vascular Biology
Oxidation of LDL by Myeloperoxidase and Reactive Nitrogen Species | Arteriosclerosis, Thrombosis, and Vascular Biology

Oxidized LDL, LOX-1 and Atherosclerosis | SpringerLink
Oxidized LDL, LOX-1 and Atherosclerosis | SpringerLink

Antioxidants | Free Full-Text | Oxidized LDLs as Signaling Molecules
Antioxidants | Free Full-Text | Oxidized LDLs as Signaling Molecules